|
⚲
|
| Alnara Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001448422 |
| Sale | 2010-01-25 ($35.0 M Offered, $20.0 M Sold) |
| Fund | |
| Phone | 6173493690 |
| Address | 840 Memorial Drive Cambridge, 02139 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| James Topper | |
| Richard Aldrich | |
| Lee Brettman | |
| Christoph Westphal | |
| Ashley Dombkowski | |
| Robert Gallotto | |
| Alexey Margolin | |
| Robert Tepper |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Under Technologies, Inc.
✚
|
0.0 | |
|
Legg Mason Partners Fund Advisor, LLC
✚
|
0.0 | |
|
BVI Core Q42024-1 Series, a Series of Blu Venture Investors
✚
|
0.0 | |
|
Peterson Ventures IV, L.P.
✚
|
0.0 | |
|
Une Femme Wines 2, a series of TBD Angels Master LLC
✚
|
0.0 | |
|
BW CDMO Co-Invest LP
✚
|
0.0 | |
|
BW Group Ltd
✚
|
0.0 | |
|
BW LPG Limited/ADR
✚
|
0.0 | |
|
BW Stone SPV I, LLC
✚
|
0.0 | |
|
BWE Kaia, LLC
✚
|
0.0 |